Safety and efficacy of rituximab in Malawi: a case for multicentre oncology clinical trials in Africa?

Lancet Glob Health

Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, MD 20892, USA. Electronic address:

Published: July 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082782PMC
http://dx.doi.org/10.1016/S2214-109X(21)00210-2DOI Listing

Publication Analysis

Top Keywords

safety efficacy
4
efficacy rituximab
4
rituximab malawi
4
malawi case
4
case multicentre
4
multicentre oncology
4
oncology clinical
4
clinical trials
4
trials africa?
4
safety
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!